4°C, and the protein concentration determined. Various dilutions in GVB ++ of the brain homogenate were incubated with undiluted autologous serum or with normal human serum obtained from a healthy adult. The mixtures were incubated at 37°C for 30 min, centrifuged, and the residual C determined. The supernatants were also tested for C3 cleavage products by crossed immunoelectrophoresis according to the method of Weeke (15) using 1% agarose in barbital buffer at pH 8.6 containing 10 mM EDTA.
Preparation of Neuronal Cells, Glial Cells, and Myelin Fractions. Whole fresh mouse brains were finely chopped with a razor blade and transferred into ice-cold 0.32 M sucrose, 10 mM Tris-HCI, pH 7.4. The minced tissue was then disrupted by passage through nylon mesh, and the suspension was sieved through mesh of descending pore size down to 50/~m. All steps were performed at 4°C. Neuronal cells, glial cells, and the myelin fraction were separated by the method of Blomstrand and Hamberger (16) . The myelin enriched fraction was further purified by the procedure of Norton and Poduslo (I 7).
Isolation of Myelin Basic protein.
Myelin basic protein (MBP) was extracted by either of the following methods. (a) This method was based on the procedure of Lira et al. (18) as modified by Golds and Braun (19) . Briefly, isolated myelin fragments that contained ~ 10 mg of MBP were partially delipidated by two extractions with 10 ml of cold acetone. The pellet containing MBP was recovered by centrifugation for 10 min at 10,000 g. MBP was solubilized from the pellet by the addition of 0.1 N HCI and stirring for 1 h at 4°C. The acid-insoluble material was removed by centrifugation and MBP was precipitated from the supernatant by the addition of 10 ml of cold acetone. The MBP precipitate was collected by centrifugation at 10,000 g for 20 min at -20°C and residual acetone removed by aspiration. (b) MBP was also solubilized directly from isolated myelin fragments without prior detipidation by stirring with 10% acetic acid containing 0.4 M NaCI for 4 h at 4°C. After centrifugation at 10,000 g the supernatant was dialyzed for 48 h against three changes of PBS.
Cross-linking of Isolated MBP. The cross-linked form of MBP was obtained by two methods.
One method was done according to Golds and Braun (20) and the other was a modified method of Golds (personal communication). In the method described by Golds and Braun (20) , 1 rag/ ml of MBP in PBS was incubated with 0.5 mg of difluorodinitrobenzene (DFDNB) (Sigma Chemical Co., St. Louis, Mo.) for 30 min at room temperature. The reaction was terminated by the addition of 3 vol of 1.0 M Tris-glycine, pH 9,0. After incubation for an additional 10 min, the cross-linked myelin fragments were recovered by centrifugation at 10,000 g for 10 min, washed three times with water, and resuspended in PBS. In the modified method 100 #g of purified MBP was reacted with 50/lg of DFDNB in 1 ml of acetone. The mixture was incubated at room temperature for 30 rain, and the reaction was terminated by the addition of 300/~l of 1 M glycine-Tris pH 9. After incubation for an additional 10 min, 1 ml of 50% trichloroacetic acid (TCA) was added and the mixture was left on ice for 15 min. After centrifugation the mixture was reacted with 1 ml of ether:ethanol (3:2) mixture at -20°C for 10 rain and centrifuged. This latter procedure was repeated three times, and the residual protein, treated with ether (-20°C) for 10 min, was resuspended in PBS to its original concentration.
Results

Consumption of C by Brain Homogenates from Adult Rabbit, Adult Mouse, and Newborn
Mouse. Fig. 1 presents the consumption of C after incubation of different concentrations of either mouse brain homogenate with NHS, or different concentration of rabbit brain homogenates with normal rabbit serum or NHS. As shown, the consumption of C by both homogenates was dose dependent. The degree of C depletion by rabbit brain homogenate was higher using rabbit serum. 6 mg protein/ml of mouse brain homogenate also reduced total hemolytic C by 37% in sera from a patient with agammaglobulinemia (<10/~g/ml IgG/ml) (data not shown).
To determine the time of appearance of the anticomplementary activity in mouse brain, homogenates of brain (6 mg/ml) of BALB/c mice at different ages were incubated with NHS. As shown in Fig. 2 , brain homogenates of newborn mice did not consume C. The anticomplementary activity first appeared 7 d after birth and thereafter increased dramatically with age. Brain homogenates of newborn rabbits were not studied.
Kinetics and Temperature Dependence of C Activation by Brain Homogenates. Brain homogenates (6 mg protein/ml) of adult rabbits or mice were incubated with NHS and aliquots were removed at timed intervals and assayed for residual TCH50. As shown in Fig. 3 , a maximum decrease of TCH50 occurred 30 min after incubation with either the mouse or rabbit brain homogenate. The consumption of TCH50 by 6 mg/ ml of either mouse or rabbit brain homogenate was also temperature dependent
PROTEIN (mg/ml) Fie. 1. Concentration-dependent depletion of TCH50 by brain homogenates. Different concentrations of BALB/c mouse brain homogenates ((D) were incubated with NHS, or rabbit brain homogenates were incubated with NHS (A) or autologous serum (V) at 32°C for 30 rain. Residual TCH50 was then determined. 
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FIo. 3. Time-dependent depletion of TCH50 by brain homogenates. Brain homogenates (6 mg/ ml in GVB ++) from BALB/c mice (O) and rabbit (l~) were incubated with equal volumes of NHS at 37°C for various times, and residual TCH50 was determined.
( Fig. 4) , and no significant differences were observed in the reactivity between the two homogenates at any temperature.
Physical Properties of Brain Homogenates. Mouse or rabbit brain homogenates were incubated at 50°C or 56°C for 30 rain and then reacted with NHS. Controls consisted of NHS incubated with GVB ++. In another experiment, brain homogenates were subjected to freezing and thawing three or five times before testing for anticomplementary activity. Table I shows that the anticomplementary activity was heat labile at 56°C for 30 min, and that freezing and thawing 5 times reduced the anticomplementary activity of mouse and rabbit brain homogenate by 26 and 9%, respectively, of the control. * Mouse and rabbit brain homogenate were treated as described, NHS added, and the mixtures incubated at 37°C for 30 rain. :[: Activities were compared with the TGH50 of NHS incubated with GVB ÷* under identical conditions. nares. Fig. 5 presents levels of residual C components in human serum following incubation with mouse brain homogenates (12 mg/ml). As shown, each of the components from C1-C7 was markedly decreased. The later components 128 and 129 did not change as much as the earlier components. C3 tested by crossed-immunoelectrophoresis showed a dramatic cleavage of C3 to C3d following incubation of NHS with 12 mg/ml brain homogenate (Fig. 6, panel A) when compared with C3 of NHS incubated with GVB ++ for the same period of time (panel C). When the concentration of mouse brain homogenate was reduced to 6 mg/ ml and incubated with NHS, native C3 as well as a C3b peak was observed (panel B).
Consumption of Human C Components and Cleavage of Human C3 by Mouse Brain Homoge-
Effect of Ca ++ and Mg +÷ on Activation of Human C3 by Mouse and Rabbit Brain
Homogenates. The requirements of Ca ++ and Mg ++ for activation of human C3 were studied next because C activation by the classical pathway requires Ca +`` and Mg ++, and the alternative pathway is strongly influenced by Mg *+ alone. Serum was chelated with 10 mM EGTA to bind Ca ++ and to prevent classical C pathway activation, and then supplemented with 1 mM Mg +÷ to allow for alternative pathway activation. Brain homogenates incubated with unchetated serum (Table II) Fie_,. 5. Hemolytic complement component titers after incubation with BALB/c mice brain homogenates. Brain homogenates (12 mg/ml in GVB ++) were incubated with equal volumes of NHS at 37°C for 30 min (tin) or for 60 rain (t2) and functional C assays were performed. activated C3 (89% using mouse brain and 100% using rabbit brain). No C3 activation occurred, however, when the same homogenates were incubated with NHS containing either Mg+÷-EGTA or EDTA (Table II) . This result indicates that the activation of C3 by brain homogenate occurs via the classical pathway.
Location of AnticomplementaTy Activity in Brain Tissue. Whole brain was separated into myelin, glial cell (astrocytes, oligodendrocytes, and microglia), neuronal cell, and cell nuclei fractions. After homogenization and adjustment to equal protein concentrations (1 mg/ml), the ability of each fraction to activate C in NHS was compared. As shown in Fig. 7 , the summarized data of eight independent experiments, >70% of the anticomplementary activity was recovered in the myelin fraction; no significant anticomplementary activity was observed with the other fractions.
Anticomplementa~y Activity of MBP. The myelin fraction described above still contained several components. Murine myelin was further purified by the method of Norton and Poduslo (17) . Approximately a third of the anticomplementary activity was still retained. The isolated murine myelin was then purified to obtain myelin basic proteins by two procedures. One procedure eliminates lipid components during isolation (19) . The other technique does not involve the use of any organic solvent during isolation (19) . The fractions of purified myelin, MBP, free myelin, and crosslinked MBP were brought up to 1 mg protein. MBP extracted by either of the two methods showed almost no anticomplementary activity (<5% reduction in TCH50). However, the myelin residues remaining after MBP extraction also possessed no anticomplementary activity (<3% reduction in TCH50). These results are shown in Fig. 8 . MBP, however, exists in nervous tissue as a dimer while extracted MBP is a monomer (19) . Purified MBP was therefore dimerized with DFDNB and reassayed for anticomplementary activity. After polymerization, MBP was now anticomplementary ( Fig. 8 ) and the specific activity per mg protein was higher than in purified myelin. Polymerized MBP-free myelin and DFDNB used as controls were not anticomplementary (data not shown). Fractionated 3-d-old mouse brain (myelin and cellular fractions) also exhibited no ability to activate C (data not shown).
In addition to the above experiments we used murine (C57B1/6) MBP purified by Fic. 6. C3 activation by BALB/c mice brain homogenate. NHS was incubated with an equal volume of (A) 12 m g / m l or (B) 6 m g / m l brain homogenates or with GVB ++ (C) for 30 min at 37°C. The sera were then subjected to cross immunoelectrophoresis to locate C3 cleavage products. The anode is to the left.
Dr. E. Barbarese. Dr. Barbarese has identified four proteins that are antigenically related to the myelin basic protein designated prelarge (mol wt 21,500), large (18,500), presmall (17,000), and small (14,000) (21) . We tested a mixture of 14K and 18.5K MBP. The purity of the two proteins we used is shown in Fig. 9 . As presented in Table III , the purified MBP (14K and 18.5K) was not anticomplementary. After dimerization according to the modified method of Golds (personal communication), complement was activated by >95%.
Discussion
Myelination of the postnatal murine central nervous system occurs in at least two stages (22) . The first stage, at 8-15 d of age, involves the proliferation of oligodendroglial cells. During the second stage, at 16 .o]
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Nuclei myelin can be observed (17) . Our data clearly indicate that the ability of the murine brain to activate complement very closely parallels the pattern of myelination. Brain homogenates from both mouse and rabbit were shown to possess anticomplementary activity. Following brain fractionation, the activity was localized in myelin.
It was further demonstrated that polymerized MBP but not monomeric MBP was anticomplementary. Dimerization of MBP by the DNDFB method has been extensively studied by Golds and Braun (20) . The reaction depends on the concentration of both the reagent and protein. In addition to reaction with amino groups on the protein, the reagent can react with sulfhydryl imidizole tyrosine-hydroxyl groups, but only the amino group modification is stable. By the above method, 20% of the MBP FIG. 7. Localization of anticomplementary activity in murine brain tissue. Whole BALB/c mice brain homogenates were fractionated on a sucrose-ficoll discontinuous gradient, and each fraction was assayed for anticomplementary activity. The percentage of total anticomplementary activity in each fraction is plotted on the graph. is dimerized and small amounts of higher heteropolymers are also produced (20) . Whether it is the MBP dimer per se or other alterations of the MBP produced by DNDFB that account for the activation of the C system by treated MBP will have to be answered by subsequent experiments. Siegel et al. (23) have reported that isolated, naturally occurring polycations including MBP activate C only in the presence of (3RP. The sera we tested for activation of (3 did not have demonstrable CRP by the method used. However, because small amounts of CRP are present in normal blood, participation by (3RP in the activation of C by myelin cannot be absolutely excluded. It seems possible that CRP may polymerize MBP or change its conformation so that it can readily activate the C system. Current hypotheses concerning the pathogenesis of postinfectious and postvaccinal disorders of the nervous system focus on the role of the cellular immune system (24) . Such hypotheses have developed largely as a result of the clinical and histopathological similarities between these human disorders and experimental allergic neuritis (EAN) and experimental allergic encephalomyelitis (EAE) in laboratory animals. Both EAN and EAE appear to result from delayed hypersensitivity to MBP. In addition, both EAE and EAN follow sensitization with nervous system antigen in the presence of Freund's complete adjuvant but not in the presence of incomplete adjuvant. The mechanism whereby a wide variety of infections, immunizations, and vaccinations induce similar sensitization to MBP has not, to date, been satisfactorily explained.
The histopathological features of postinfectious diseases of the nervous system have been recently reviewed (24) . It was postulated that perivascular demyelination may also result from vascular injury alone, in the absence of delayed hypersensitivity reactions. The recent detection of antigen-antibody complexes circulating in the sera of patients with a variety of neurological disorders (25, 26) suggests a pathologic mechanism whereby the complexes induce a primary vascular lesion that, in turn, leads to demyelination. The present study suggests that neuronal tissue necrosis resulting in the exposure and/or release of MBP can lead to activation of the (2 system in the absence of autoantibodies. Since MBP is detected in sera and cerebral spinal fluids after brain injury (27) and in patients with multiple sclerosis (28) , such C activation may be responsible, at least in part, for the development of acute inflammation, magnification of the damaged area, and the occurrence of vascular spasms following brain hemorrhage.
Summary
Murine or rabbit whole brain homogenates were shown to activate human complement via the classical pathway by an antibody-independent reaction. This activity required Ca ~:+ ions. Anticomplementary activity in fractionated murine brain was found to reside in the myelin fraction and in purified myelin. It was absent, however, both from highly purified myelin basic protein (MBP) and from the MBP-free residue. Because purified MBP is a monomer and this protein exists in brain tissue largely as a dimer, the ability of the cross-linked form of MBP to activate complement was investigated. MBP, dimerized with difluorodinitrobenzene, was highly anticomplementary. The murine brain, inactive when taken from the newborn mouse, was shown to first acquire the capacity to activate complement at 7 d after birth. This finding is consistent with the report that the synthesis of myelin protein has been shown to be initiated in murine brain 8 d after birth. Complement activation by MBP could play an important role in the pathological changes observed in neurological disorders.
